Trade MerckCo USA ^MRK

Sumitomo Mitsui Trust Group Inc. Sells 190,066 Shares of Merck & Co., Inc. $MRK

1,793,130 Shares in Merck & Co., Inc. $MRK Bought by Mirae Asset Global Investments Co. Ltd.

Profund Advisors LLC Purchases 7,628 Shares of Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Stock: Vise Technologies Inc. Boosts Holdings

Promising Pharmaceutical Stocks To Follow Today - October 31st - Stock Observer

Merck & Co., Inc. $MRK Stock: Raleigh Capital Management Inc. Cuts Holdings - Markets Daily

Merck & Co., Inc. $MRK Position Cut by Raleigh Capital Management Inc.

Merck & Co., Inc. $MRK Shares Acquired by Renaissance Investment Group LLC

Merck & Co., Inc. (NYSE:MRK) Given New $171.00 Price Target at Guggenheim - Zolmax

Merck & Co., Inc. (NYSE:MRK) Stock Has Average Price Target of $156.08 According to Brokerages

Merck & Co., Inc. $MRK Shares Sold by Americana Partners LLC

VIRGINIA RETIREMENT SYSTEMS ET Al Sells 222,800 Shares of Merck & Co., Inc. $MRK - Stock Observer

Merck & Co., Inc. (NYSE:MRK) Stock Price Breaks Above 50-Day Moving Average After Analyst Downgrade

Merck (NYSE: MRK) lifts sales outlook midpoint but third-quarter GAAP EPS falls 12% - Zolmax

Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Increase from JPMorgan Chase & Co.

Merck & Co., Inc. (NYSE:MRK) Posts Quarterly Earnings Results, Beats Expectations By $0.40 EPS - Markets Daily

CMMB Celebrates New Distribution Center at the Brethren Service Center with Ribbon-Cutting Ceremony

Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says

Merck & Co., Inc. Q3 Earnings Call Highlights

Merck & Co., Inc. $MRK Stake Lessened by Soltis Investment Advisors LLC

Merck & Co., Inc. (NYSE:MRK) Releases Earnings Results

Merck & Co., Inc. Q3 2026 Earnings Call Summary

Merck & Co., Inc. (MRK) Stock: Jumps 3.84% as Q3 2026 Revenue Rises 5% to $18.1 Billion

Merck Reports Q3 Revenue of $18.1 Billion, Raises 2026 Earnings Guidance

Merck 3Q Revenue Up on Keytruda, Winrevair Growth - Update | Morningstar

Merck Boosts FY26 Outlook - Update

Merck 3Q Revenue Up on Keytruda, Winrevair Growth | Morningstar

Merck & Co Inc. Q3 Income Retreats

Merck & Co Q3 26 Earnings Conference Call At 9:00 AM ET

17,813 Merck & Co., Inc. $MRK Shares Sold by D.A. Davidson & CO.

Merck & Co., Inc. $MRK Shares Sold by Convergence Financial LLC

12,469 Merck & Co., Inc. $MRK Shares Sold by Bokf Na

Health Sciences Authority of Singapore approves MSD's CAPVAXIVE pneumococcal 21-valent conjugate vaccine for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults

5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial

Merck News | Markets Insider

Top Pharmaceutical Stocks To Follow Now - October 28th - Zolmax

13,296 Shares in Moderna, Inc. $MRNA Bought by Great Lakes Retirement Inc.

Merck & Co., Inc. $MRK Stock Purchased by DMC Group LLC - Markets Daily

Generali Asset Management SPA SGR Purchases 17,772 Shares of Merck & Co., Inc. $MRK - Stock Observer

Pharmaceutical Stocks To Research - October 27th - Zolmax

Moderna, Inc. (NASDAQ:MRNA) Stock Has Average Price Target of $101.45 - Markets Daily

FY2028 EPS Estimate for Moderna Cut by Analyst - Zolmax

Robeco Institutional Asset Management B.V. Makes New Investment in Moderna, Inc. $MRNA

New Indication Application for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Accepted for Review by NMPA

Merck & Co., Inc. $MRK Position Lifted by Oppenheimer & Co. Inc.

Leo Wealth LLC Makes New Investment in Merck & Co., Inc. $MRK

23,115 Merck & Co., Inc. $MRK Shares Sold by apricus wealth LLC

Merck & Co., Inc. $MRK Stock: Oppenheimer & Co. Inc. Boosts Stake - Daily Political

FY2028 EPS Forecast for Moderna Lowered by Analyst - Daily Political

FY2030 EPS Estimate for Moderna Lowered by Analyst - Zolmax

Merck's KEYTRUDA Cuts Progression Risk By 43% In Phase 3 Endometrial Cancer Trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

Barclays Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price

Best Healthcare Stocks To Watch Today - October 26th - Stock Observer

Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Increase from Barclays - Stock Observer

Apollon Wealth Management LLC Purchases 46,936 Shares of Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Holdings Lessened by Sigma Planning Corp - Daily Political

Barclays Reaffirms Their Buy Rating on Merck & Company (MRK)

Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Merck & Company (MRK)

Merck & Co., Inc. $MRK Stake Boosted by Norris Perne & French LLP MI - Markets Daily

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine

Merck & Co., Inc. $MRK Stock: Valley National Advisers Inc. Lowers Holdings

Merck & Co., Inc. $MRK Position Trimmed by Middleton & Co. Inc. MA

Merck & Co., Inc. $MRK Stock: Mondrian Investment Partners LTD Cuts Holdings

Merck & Co., Inc. $MRK Stock Sold by Carolina Wealth Advisors LLC

Merck & Co., Inc. $MRK Stock Bought by Norris Perne & French LLP MI - Stock Observer

Evergreen Capital Management LLC Sells 69,731 Shares of Merck & Co., Inc. $MRK

BG Investment Services LLC Makes New $5.39 Million Investment in Merck & Co., Inc. $MRK

17,497 Merck & Co., Inc. $MRK Shares Acquired by Bernardo Wealth Planning LLC

Merck & Co., Inc. $MRK Holdings Decreased by Sterling Capital Management LLC - Stock Observer

Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO

Merck & Co., Inc. $MRK Stock Sold by Capital Investment Advisors LLC

Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial

Interpath-100: data leak, stock drop, spirited defense by ESMO president

Merck & Co., Inc. $MRK Stock: Investment House LLC Reduces Position

Ophthalmology Sector Emerges as Must-Win Battleground for Global Pharma: Eli Lilly, Merck & Co., AbbVie, Innovent Biologics, Hengrui Medicine and Leading Players Enter the Market

Moderna, Inc. (NASDAQ:MRNA) Stock Has Consensus Target Price of $101.45 According to Analysts - Stock Observer

Oncologists cheer melanoma data that tanked Moderna's shares | News & Features | ArcaMax Publishing

Moderna, Merck shares fall on eagerly anticipated cancer vaccine results

Moderna, Merck Shares Fall After Possible Melanoma Data Leak

6,761 Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas

Top Pharmaceutical Stocks To Add to Your Watchlist - October 22nd - Daily Political

Merck & Co., Inc. $MRK Stock Sold by Inlet Private Wealth LLC

Merck & Co., Inc. $MRK Stock Sold by Crossmark Global Holdings Inc.

Merck & Co., Inc. $MRK Shares Purchased by Diversify Advisory Services LLC

Merck & Co., Inc. (MRK) Set to Release Earnings on Thursday

Merck & Co., Inc. $MRK Stock Holdings Lowered by Cantor Fitzgerald Investment Advisors L.P.

27,739 Merck & Co., Inc. $MRK Shares Sold by Axxcess Wealth Management LLC

Merck & Co., Inc. $MRK Stock Sold by Smith Chas P & Associates PA Cpas - Daily Political

Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?

Gold Price Forecast UAE 2026–2030: What Could 24K Gold Cost per Gram?

CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?

Pound to Rand Forecast: Can GBP/ZAR Break Above 22?

Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

US Dollar Index Holds Near 102 Ahead of US Midterm Elections

Gold Price Today: Gold Reclaims $3,900 as Fed Rate Concerns Weigh on Recovery

Palantir Q3 Earnings Preview: Can AI Growth Support PLTR’s Valuation?

AMD Earnings Preview: Can AI Chip Growth Reverse the Stock’s 11% Sell-Off?

Gold Price Forecast This Week: Can XAU/USD Recover After Crashing Below $3,900?

Intel Stock Plunges About 30% as Alphabet Sell-Off Deepens AI Spending Concerns

US Midterm Elections 2026: What the Results Could Mean for Stocks, Gold and the US Dollar

Oil Price Today: Brent Falls Below $112 as Iran Talks Ease Supply Fears